Kan. Stat. § 65-4109
(1) | Any compound, mixture or preparation containing: | ||
(A) | Amobarbital | 2126 | |
(B) | Secobarbital | 2316 | |
(C) | Pentobarbital or any salt thereof and one or more other active medicinal ingredients which are not listed in any schedule | 2271 | |
(2) | Any suppository dosage form containing: | ||
(A) | Amobarbital | 2126 | |
(B) | Secobarbital | 2316 | |
(C) | Pentobarbital or any salt of any of these drugs and approved by the Food and Drug Administration for marketing only as a suppository. | 2271 | |
(3) | Any substance which contains any quantity of a derivative of barbituric acid, or any salt of a derivative of barbituric acid, except those substances which are specifically listed in other schedules | 2100 | |
(4) | Chlorhexadol | 2510 | |
(5) | Lysergic acid | 7300 | |
(6) | Lysergic acid amide | 7310 | |
(7) | Methyprylon | 2575 | |
(8) | Sulfondiethylmethane | 2600 | |
(9) | Sulfonethylmethane | 2605 | |
(10) | Sulfonmethane | 2610 | |
(11) | Tiletamine and zolazepam or any salt thereof Some trade or other names for a tiletamine-zolazepam combination product: Telazol Some trade or other names for tiletamine: 2-(ethylamino)-2-(2-thienyl)-cyclohexanone Some trade or other names for zolazepam: 4-(2-fluorophenyl)-6,8-dihydro-1,3,8-trimethylpyrazolo-[3,4-e][1,4]-diazepin-7(1H)-one, flupyrazapon | 7295 | |
(12) | Ketamine, its salts, isomers, and salts of isomers Some other names for ketamine: (±)-2-(2-chlorophenyl)-2-(methylamino)-cyclohexanone | 7285 | |
(13) | Gamma hydroxybutyric acid, any salt, hydroxybutyric compound, derivative or preparation of gamma hydroxybutyric acid contained in a drug product for which an application has been approved under section 505 of the federal food, drug and cosmetic act | ||
(14) | Embutramide | 2020 | |
(15) | Perampanel, its salts, isomers, and salts of isomers Some other names for perampanel: 2-(2-oxo-1-phenyl-5-pyridin-2-yl-1,2 dihydropyridin-3-yl) benzonitrile | 2261 | |
(1) | Not more than 1.8 grams of codeine or any of its salts per 100 milliliters or not more than 90 milligrams per dosage unit with an equal or greater quantity of an isoquinoline alkaloid of opium | 9803 | |
(2) | not more than 1.8 grams of codeine or any of its salts per 100 milliliters or not more than 90 milligrams per dosage unit with one or more active, nonnarcotic ingredients in recognized therapeutic amounts | 9804 | |
(3) | not more than 1.8 grams of dihydrocodeine or any of its salts per 100 milliliters or not more than 90 milligrams per dosage unit with one or more active, nonnarcotic ingredients in recognized therapeutic amounts | 9807 | |
(4) | not more than 300 milligrams of ethylmorphine or any of its salts per 100 milliliters or not more than 15 milligrams per dosage unit with one or more active, nonnarcotic ingredients in recognized therapeutic amounts | 9808 | |
(5) | not more than 500 milligrams of opium per 100 milliliters or per 100 grams or not more than 25 milligrams per dosage unit with one or more active, nonnarcotic ingredients in recognized therapeutic amounts | 9809 | |
(6) | not more than 50 milligrams of morphine or any of its salts per 100 milliliters or per 100 grams with one or more active, nonnarcotic ingredients in recognized therapeutic amounts | 9810 | |
(7) | any material, compound, mixture or preparation containing any of the following narcotic drugs or their salts, as set forth below: | ||
(A) | Buprenorphine | 9064 | |
(1) | Those compounds, mixtures or preparations in dosage unit form containing any stimulant substance listed in schedule II, which compounds, mixtures or preparations were listed on August 25, 1971, as excepted compounds under section 308.32 of title 21 of the code of federal regulations, and any other drug of the quantitive composition shown in that list for those drugs or which is the same, except that it contains a lesser quantity of controlled substances | 1405 |
(2) | Benzphetamine | 1228 |
(3) | Chlorphentermine | 1645 |
(4) | Chlortermine | 1647 |
(5) | Phendimetrazine | 1615 |
"Anabolic steroid" means any drug or hormonal substance, chemically and pharmacologically related to testosterone (other than estrogens, progestins, and corticosteroids) that promotes muscle growth, and includes:
(1) | 3[BETA],17-dihydroxy-5a-androstane | |
(2) | 3[ALPHA],17[BETA]-dihydroxy-5a-androstane | |
(3) | 5a-androstan-3,17-dione | |
(4) | 1-androstenediol (3[BETA],17[BETA]-dihydroxy-5[ALPHA]-androst-1-ene) | |
(5) | 1-androstenediol (3[ALPHA],17[BETA]-dihydroxy-5[ALPHA]-androst-1-ene) | |
(6) | 4-androstenediol (3[BETA],17[BETA]-dihydroxy-androst-4-ene) | |
(7) | 5-androstenediol (3[BETA],17[BETA]-dihydroxy-androst-5-ene) | |
(8) | 1-androstenedione ([5[ALPHA]]-androst-1-en-3,17-dione) | |
(9) | 4-androstenedione (androst-4-en-3,17-dione) | |
(10) | 5-androstenedione (androst-5-en-3,17-dione) | |
(11) | bolasterone (7[ALPHA],17[ALPHA]-dimethyl-17[BETA]-hydroxyandrost-4-en-3-one) | |
(12) | boldenone (17[BETA]-hydroxyandrost-1,4-diene-3-one) | |
(13) | boldione (androsta-1,4-diene-3,17-dione) | |
(14) | calusterone (7[BETA],17[ALPHA]-dimethyl-17[BETA]-hydroxyandrost-4-en-3-one) | |
(15) | clostebol (4-chloro-17[BETA]-hydroxyandrost-4-en-3-one) | |
(16) | dehydrochloromethyltestosterone (4-chloro-17[BETA]-hydroxy-17[ALPHA]-methyl-androst-1,4-dien-3-one) | |
(17) | desoxymethyltestosterone (17[ALPHA]-methyl-5[ALPHA]-androst-2-en-17[BETA]-ol) (also known as "madol") | |
(18) | [DELTA]1-dihydrotestosterone (17[BETA]-hydroxy-5[ALPHA]-androst-1-en-3-one) (also known as "1-testosterone") | |
(19) | 4-dihydrotestosterone (17[BETA]-hydroxy-androstan-3-one) | |
(20) | drostanolone (17[BETA]-hydroxy-2[ALPHA]-methyl-5[ALPHA]-androstan-3-one) | |
(21) | ethylestrenol (17[ALPHA]-ethyl-17[BETA]-hydroxyestr-4-ene) | |
(22) | fluoxymesterone (9-fluoro-17[ALPHA]-methyl-11[BETA],17[BETA]-dihydroxyandrost-4-en-3-one) | |
(23) | formebolone (2-formyl-17[ALPHA]-methyl-11[ALPHA],17[BETA]-dihydroxyandrost-1,4-dien-3-one) | |
(24) | furazabol (17[ALPHA]-methyl-17[BETA]-hydroxyandrostano[2,3-c]-furazan) | |
(25) | 13[BETA]-ethyl-17[BETA]-hydroxygon-4-en-3-one | |
(26) | 4-hydroxytestosterone (4,17[BETA]-dihydroxy-androst-4-en-3-one) | |
(27) | 4-hydroxy-19-nortestosterone (4,17[BETA]-dihydroxy-estr-4-en-3-one) | |
(28) | mestanolone (17[ALPHA]-methyl-17[BETA]-hydroxy-5-androstan-3-one) | |
(29) | mesterolone (1[ALPHA]-methyl-17[BETA]-hydroxy-[5[ALPHA]]-androstan-3-one) | |
(30) | methandienone (17[ALPHA]-methyl-17[BETA]-hydroxyandrost-1,4-dien-3-one) | |
(31) | methandriol (17[ALPHA]-methyl-3[BETA],17[BETA]-dihydroxyandrost-5-ene) | |
(32) | methasterone (2[ALPHA],17[ALPHA]-dimethyl-5[ALPHA]-androstan-17[BETA]-ol-3-one) | |
(33) | methenolone (1-methyl-17[BETA]-hydroxy-5[ALPHA]-androst-1-en-3-one) | |
(34) | 17[ALPHA]-methyl-3[BETA],17[BETA]-dihydroxy-5a-androstane | |
(35) | 17[ALPHA]-methyl-3[ALPHA],17[BETA]-dihydroxy-5a-androstane | |
(36) | 17[ALPHA]-methyl-3[BETA],17[BETA]-dihydroxyandrost-4-ene | |
(37) | 17[ALPHA]-methyl-4-hydroxynandrolone (17[ALPHA]-methyl-4-hydroxy-17[BETA]-hydroxyestr-4-en-3-one) | |
(38) | methyldienolone (17[ALPHA]-methyl-17[BETA]-hydroxyestra-4,9(10)-dien-3-one) | |
(39) | methyltrienolone (17[ALPHA]-methyl-17[BETA]-hydroxyestra-4,9,11-trien-3-one) | |
(40) | methyltestosterone (17[ALPHA]-methyl-17[BETA]-hydroxyandrost-4-en-3-one) | |
(41) | mibolerone (7[ALPHA],17[ALPHA]-dimethyl-17[BETA]-hydroxyestr-4-en-3-one) | |
(42) | 17[ALPHA]-methyl-[DELTA]1-dihydrotestosterone (17[BETA]-hydroxy-17[ALPHA]-methyl-5[ALPHA]-androst-1-en-3-one) (also known as "17-[ALPHA]-methyl-1-testosterone") | |
(43) | nandrolone (17[BETA]-hydroxyestr-4-en-3-one) | |
(44) | 19-nor-4-androstenediol (3[BETA], 17[BETA]-dihydroxyestr-4-ene) | |
(45) | 19-nor-4-androstenediol (3[ALPHA], 17[BETA]-dihydroxyestr-4-ene) | |
(46) | 19-nor-5-androstenediol (3[BETA], 17[BETA]-dihydroxyestr-5-ene) | |
(47) | 19-nor-5-androstenediol (3[ALPHA], 17[BETA]-dihydroxyestr-5-ene) | |
(48) | 19-nor-4,9(10)-androstadienedione (estra-4,9(10)-diene-3,17-dione) | |
(49) | 19-nor-4-androstenedione (estr-4-en-3,17-dione) | |
(50) | 19-nor-5-androstenedione (estr-5-en-3,17-dione) | |
(51) | norbolethone (13[BETA], 17[ALPHA]-diethyl-17[BETA]-hydroxygon-4-en-3-one) | |
(52) | norclostebol (4-chloro-17[BETA]-hydroxyestr-4-en-3-one) | |
(53) | norethandrolone (17[ALPHA]-ethyl-17[BETA]-hydroxyestr-4-en-3-one) | |
(54) | normethandrolone (17[ALPHA]-methyl-17[BETA]-hydroxyestr-4-en-3-one) | |
(55) | oxandrolone (17[ALPHA]-methyl-17[BETA]-hydroxy-2-oxa-[5[ALPHA]]-androstan-3-one) | |
(56) | oxymesterone (17[ALPHA]-methyl-4,17[BETA]-dihydroxyandrost-4-en-3-one) | |
(57) | oxymetholone (17[ALPHA]-methyl-2-hydroxymethylene-17[BETA]-hydroxy-[5[ALPHA]]-androstan-3-one) | |
(58) | prostanozol (17[BETA]-hydroxy-5[ALPHA]-androstano[3,2-c]pyrazole) | |
(59) | stanozolol (17[ALPHA]-methyl-17[BETA]-hydroxy-[5[ALPHA]]-androst-2-eno[3,2-c]-pyrazole) | |
(60) | stenbolone (17[BETA]-hydroxy-2-methyl-[5[ALPHA]]-androst-1-en-3-one) | |
(61) | testolactone (13-hydroxy-3-oxo-13,17-secoandrosta-1,4-dien-17-oic acid lactone) | |
(62) | testosterone (17[BETA]-hydroxyandrost-4-en-3-one) | |
(63) | tetrahydrogestrinone (13[BETA], 17[ALPHA]-diethyl-17[BETA]-hydroxygon-4,9,11-trien-3-one) | |
(64) | trenbolone (17[BETA]-hydroxyestr-4,9,11-trien-3-one) | |
(65) | any salt, ester, or isomer of a drug or substance described or listed in this paragraph, if that salt, ester, or isomer promotes muscle growth. | |
(A) | Except as provided in (B), such term does not include an anabolic steroid which is expressly intended for administration through implants to cattle or other nonhuman species and which has been approved by the United States' secretary of health and human services for such administration. | |
(B) | If any person prescribes, dispenses or distributes such steroid for human use, such person shall be considered to have prescribed, dispensed or distributed an anabolic steroid within the meaning of this subsection (f). | |
(1) | Dronabinol (synthetic) in sesame oil and encapsulated in a soft gelatin capsule in a United States food and drug administration approved product | 7369 |
Some other names for dronabinol: (6aR-trans)-6a,7,8,10a-tetrahydro -6-6-9-trimethyl-3-pentyl-6H-dibenzo(b,d)pyran-1-0l, or (-)-delta-9-(trans)-tetrahydrocannabinol. |
K.S.A. 65-4109
Revisor's Note:
Section was also amended by L. 2011, ch. 10, § 3, but that version was repealed by L. 2011, ch. 83, § 9.